RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $436,764 | -16.1% | 404,411 | +0.2% | 0.00% | 0.0% |
Q2 2023 | $520,471 | +1.3% | 403,466 | +3.7% | 0.00% | 0.0% |
Q1 2023 | $513,654 | -14.7% | 389,132 | -3.1% | 0.00% | -33.3% |
Q4 2022 | $602,384 | +80.9% | 401,589 | +42.3% | 0.00% | +50.0% |
Q3 2022 | $333,000 | +20.7% | 282,239 | +15.5% | 0.00% | +100.0% |
Q2 2022 | $276,000 | -63.3% | 244,429 | -2.8% | 0.00% | -66.7% |
Q1 2022 | $752,000 | +12.7% | 251,529 | 0.0% | 0.00% | +50.0% |
Q4 2021 | $667,000 | -26.9% | 251,529 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $913,000 | -23.5% | 251,529 | -8.6% | 0.00% | -20.0% |
Q2 2021 | $1,194,000 | +21.5% | 275,109 | -4.3% | 0.01% | +25.0% |
Q1 2021 | $983,000 | -66.1% | 287,499 | -65.3% | 0.00% | -66.7% |
Q4 2020 | $2,896,000 | +28.2% | 827,421 | -12.1% | 0.01% | +20.0% |
Q3 2020 | $2,259,000 | +31.2% | 941,392 | +0.0% | 0.01% | +25.0% |
Q2 2020 | $1,722,000 | +102.4% | 941,050 | +72.5% | 0.01% | +60.0% |
Q1 2020 | $851,000 | +55.0% | 545,684 | +112.8% | 0.01% | +66.7% |
Q4 2019 | $549,000 | +66.9% | 256,410 | +45.8% | 0.00% | +50.0% |
Q3 2019 | $329,000 | -28.3% | 175,895 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $459,000 | +1.5% | 175,895 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $452,000 | +11.6% | 175,895 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $405,000 | -35.2% | 175,895 | -9.7% | 0.00% | 0.0% |
Q3 2018 | $625,000 | +78.1% | 194,830 | +57.2% | 0.00% | +50.0% |
Q2 2018 | $351,000 | -43.9% | 123,930 | -23.2% | 0.00% | -71.4% |
Q1 2014 | $626,000 | – | 161,310 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |